Free Trial

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Given Average Rating of "Buy" by Analysts

Reckitt Benckiser Group logo with Consumer Staples background

Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) have received a consensus rating of "Buy" from the eight ratings firms that are presently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and four have given a strong buy rating to the company.

Separately, Sanford C. Bernstein upgraded Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th.

Read Our Latest Report on RBGLY

Reckitt Benckiser Group Stock Performance

Shares of RBGLY stock traded up $0.09 during trading hours on Friday, reaching $13.86. 209,951 shares of the stock were exchanged, compared to its average volume of 282,552. The business's fifty day moving average is $13.67 and its two-hundred day moving average is $13.24. The company has a quick ratio of 0.39, a current ratio of 0.58 and a debt-to-equity ratio of 1.08. Reckitt Benckiser Group has a 12-month low of $10.43 and a 12-month high of $14.15.

Reckitt Benckiser Group Company Profile

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Should You Invest $1,000 in Reckitt Benckiser Group Right Now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines